Bejelentkezés Regisztrálj ingyen

Hancock Jaffe Laboratories Inc Előre P/E

Mi az Hancock Jaffe Laboratories Inc Előre P/E?

A Előre P/E az Hancock Jaffe Laboratories Inc - -6.70

Mi a Előre P/E meghatározása?



Az előrejelzett ár / jövedelem arány a vállalat tőzsdei árának és a társaság becsült részvényenkénti eredményének aránya a következő tizenkét hónapban.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Előre P/E a Health Care szektor a NASDAQ-on cégekben a Hancock Jaffe Laboratories Inc -hoz képest

Mit csinál Hancock Jaffe Laboratories Inc?

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

előre p/e -hoz hasonló cégek Hancock Jaffe Laboratories Inc